Trial Profile
A retrospective study accessing the safety and tolerability of Lisdexamfetamine in children with Attention-deficit hyperactivity disorder (ADHD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2015
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions
- 16 Oct 2015 New trial record